$42.78Day Range$43.54
Key Statistics
Market Cap
$191.03B
Shares Outstanding
4,417.9M
Primary Exchange
XNYS
Currency
USD
Type
ADRC
IPO Date
Apr 30, 1981
Round Lot
100
Locale
US
Trading Data
Day Open
$43.50
Day High
$43.54
Day Low
$42.78
Volume
10.37M
VWAP
$43.22
Prev Close
$43.19
Transactions
--
Acc. Volume
--
About Novo-Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Identifiers
- CIK
- 0000353278
- Composite FIGI
- BBG000BQBKR3
- Share Class FIGI
- BBG001S5TSK0
- Ticker Root
- NVO
About Novo-Nordisk A/S (NVO) Stock
Novo-Nordisk A/S (NVO) closed the 2026-09-18 session at $43.24, up 0.12% versus the previous close (+0.05). The stock opened at $43.50 and traded between $42.78 and $43.54 during that session. Session trading volume was 10.4M shares. The volume-weighted average price (VWAP) is $43.22.
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Novo-Nordisk A/S has a market capitalization of $191.03 billion. NVO is listed on the XNYS exchange. The company employs approximately 69,500 people. The recorded listing date is 1981-04-30.
On this page you can find market NVO stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors.